Clinical Trial Update: Zepatier in Patients with Substance Use

View source ↗

Summary

A clinical trial update indicates that Zepatier (elbasvir/grazoprevir) has completed a study in patients with hepatitis C who have substance use disorders, incl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C
• Substance Use Disorder

Drugs mentioned

• Zepatier (elbasvir/grazoprevir)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Hepatitis C, Hiv | Status: COMPLETED